- Home
- RFL vs CATO Comparison
RFL vs CATO Comparison
Compare RFL & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RFL | CATO |
|---|---|---|
| Founded | 2017 | 1946 |
| Country | United States | United States |
| Employees | N/A | 7000 |
| Industry | Real Estate | Clothing/Shoe/Accessory Stores |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.1M | 60.0M |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RFL | CATO |
|---|---|---|
| Price | $1.34 | $2.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 92.9K | 49.1K |
| Earning Date | 03-30-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.28 | 17.09 |
| EPS | N/A | ★ 0.25 |
| Revenue | $917,000.00 | ★ $649,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.16 |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $1.12 | $2.19 |
| 52 Week High | $3.19 | $4.92 |
Technical Indicators
Market Signals| Indicator | RFL | CATO |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 45.19 |
| Support Level | $1.15 | $2.81 |
| Resistance Level | $1.38 | $3.22 |
| Average True Range (ATR) | 0.12 | 0.18 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 30.00 | 17.31 |
Price Performance
Historical ComparisonAbout RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.